Ocean Biomedical, Inc. (OCEA): R&D Expense
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$26.0K
Year ended 2024-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $26.0K | -96.3% | 2025-04-08, From 2024-01-01 |
| 2023-12-31 | $709.0K | -91.6% | 2025-04-08, From 2023-01-01 |
| 2022-12-31 | $8.41M | n/a | 2024-11-25, From 2022-01-01 |